Found: 28
Select item for more details and to access through your institution.
Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 1, doi. 10.3350/cmh.2022.0017
- By:
- Publication type:
- Article
Management of refractory ascites.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 16, doi. 10.3350/cmh.2022.0104
- By:
- Publication type:
- Article
Wnt signaling in liver regeneration, disease, and cancer.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 33, doi. 10.3350/cmh.2022.0058
- By:
- Publication type:
- Article
Development and prognosis of hepatocellular carcinoma in patients with diabetes.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 51, doi. 10.3350/cmh.2022.0095
- By:
- Publication type:
- Article
Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 65, doi. 10.3350/cmh.2022.0032
- By:
- Publication type:
- Article
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 77, doi. 10.3350/cmh.2022.0237
- By:
- Publication type:
- Article
The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 99, doi. 10.3350/cmh.2022.0321
- By:
- Publication type:
- Article
The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 102, doi. 10.3350/cmh.2022.0353
- By:
- Publication type:
- Article
Non-invasive tests-based risk stratification: Baveno VII and beyond.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 105, doi. 10.3350/cmh.2022.0361
- By:
- Publication type:
- Article
Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 110, doi. 10.3350/cmh.2022.0414
- By:
- Publication type:
- Article
Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 113, doi. 10.3350/cmh.2022.0333
- By:
- Publication type:
- Article
New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 118, doi. 10.3350/cmh.2022.0413
- By:
- Publication type:
- Article
Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 120, doi. 10.3350/cmh.2021.0395
- By:
- Publication type:
- Article
Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 135, doi. 10.3350/cmh.2022.0181
- By:
- Publication type:
- Article
Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 146, doi. 10.3350/cmh.2022.0172
- By:
- Publication type:
- Article
Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 163, doi. 10.3350/cmh.2022.0326
- By:
- Publication type:
- Article
Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 165, doi. 10.3350/cmh.2022.0339
- By:
- Publication type:
- Article
Letter regarding “COVID-19 vaccine immunoge- nicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 168, doi. 10.3350/cmh.2022.0328
- By:
- Publication type:
- Article
Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 169, doi. 10.3350/cmh.2022.0384
- By:
- Publication type:
- Article
Reply to Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 171, doi. 10.3350/cmh.2022.0381
- By:
- Publication type:
- Article
Reply to Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 173, doi. 10.3350/cmh.2022.0372
- By:
- Publication type:
- Article
Reply to Letter regarding “COVID-19 vaccine im- munogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 176, doi. 10.3350/cmh.2022.0377
- By:
- Publication type:
- Article
Reply to Letter regarding “The usefulness of meta- bolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 179, doi. 10.3350/cmh.2022.0409
- By:
- Publication type:
- Article
Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 182, doi. 10.3350/cmh.2022.0411
- By:
- Publication type:
- Article
Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 185, doi. 10.3350/cmh.2022.0375
- By:
- Publication type:
- Article
Correspondence on Editorial regarding “BavenoVII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 188, doi. 10.3350/cmh.2022.0408
- By:
- Publication type:
- Article
Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 191, doi. 10.3350/cmh.2022.0410
- By:
- Publication type:
- Article
Epidemiology and updated management for autoimmune liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 1, p. 194, doi. 10.3350/cmh.2022.0387
- By:
- Publication type:
- Article